Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.295
-0.045 (-3.36%)
At close: Oct 10, 2025, 4:00 PM EDT
1.290
-0.005 (-0.39%)
After-hours: Oct 10, 2025, 7:59 PM EDT

Ernexa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
101510172177
Upgrade
Market Cap Growth
77.39%48.54%-38.39%-92.39%3176.58%4.10%
Upgrade
Enterprise Value
6.5613.8642.225.95202.247.62
Upgrade
Last Close Price
1.304.4128.2048.301251.001344.00
Upgrade
PE Ratio
--0.09-0.46-0.40-1.47-10.93
Upgrade
PS Ratio
7.9725.96149.57---
Upgrade
PB Ratio
2.268.884.551.368.510.86
Upgrade
P/TBV Ratio
0.842.364.470.817.0810.29
Upgrade
P/FCF Ratio
--0.93-0.50-0.78-9.18-0.81
Upgrade
P/OCF Ratio
--0.95-0.50-0.79-9.24-0.82
Upgrade
EV/Sales Ratio
13.4423.81620.94---
Upgrade
EV/EBITDA Ratio
--1.16-2.14-0.18-1.79-1.07
Upgrade
EV/EBIT Ratio
--0.74-2.00-0.18-1.78-1.05
Upgrade
EV/FCF Ratio
--0.86-2.07-0.28-8.55-0.94
Upgrade
Debt / Equity Ratio
0.080.2817.750.070.090.34
Upgrade
Debt / EBITDA Ratio
-0.05-0.06-2.12-0.04-0.02-0.40
Upgrade
Debt / FCF Ratio
-0.04-0.04-2.05-0.06-0.11-0.36
Upgrade
Asset Turnover
0.080.020.00000
Upgrade
Quick Ratio
1.690.741.221.624.810.52
Upgrade
Current Ratio
1.810.801.461.795.100.55
Upgrade
Return on Equity (ROE)
-320.65%-2421.50%-300.64%-120.22%-621.92%-114.37%
Upgrade
Return on Assets (ROA)
-183.34%-69.17%-59.20%-123.23%-511.63%-53.63%
Upgrade
Return on Capital (ROIC)
-373.27%-81.32%-78.07%-271.31%-894.80%-59.88%
Upgrade
Return on Capital Employed (ROCE)
-325.52%-83.88%-73.92%-156.41%-604.49%-81.39%
Upgrade
Earnings Yield
-425.33%-1108.84%-217.02%-250.31%-67.88%-9.15%
Upgrade
FCF Yield
-140.54%-107.26%-200.84%-128.86%-10.90%-122.95%
Upgrade
Buyback Yield / Dilution
0.00%-7.53%-3.15%-119.37%-28.83%-65.84%
Upgrade
Total Shareholder Return
--7.53%-3.15%-119.37%-28.83%-65.84%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q